NCT04389593Completed
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
Source: ClinicalTrials.gov · Last updated 25 Nov 2024
Brief summary (registry, in English)
This pilot study will evaluate conventional and investigational MR imaging and spectroscopic sequences and collect data to help plan more definitive future studies.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 26 Feb 2020
- Start date
- May 2019
- Primary completion date
- Jul 2024
- Lead sponsor
- University of California, San Diego
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT04389593
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From May 2019 to the primary completion date, Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \< 18 years of age
Other
- VA subject
- Subject does not have a physician and does not wish to be contacted about possible incidental findings
- MRI contraindication(s)
- Subject knows that she is pregnant or states she is trying to become pregnant
Who the study is looking for
- Adult subjects of any gender and any ethnic group with known or suspected NASH
- Subject is willing and able to complete required research procedures (screening/enrollment, clinical evaluation, safety procedures, and research MRI exam), and is willing to allow the study team to review clinical data including but not limited to other clinical radiology reports and images and clinical or research biopsy results
- Subject has been fully informed and has personally signed and dated the written Informed Consent and Health Insurance Portability and Accountability Act (HIPAA) documents
- Subject has had or is expected to have a clinical or research biopsy within 150 days of the MR exam
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Diego Coordinator of this site? Confirm its status | La Jolla | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.